Let's hope so.....a slow grind higher in valuation is always better than a pop in my experience. If a company brings investment dollars with it's story, they tend to stick.
In saying that...the alternative is a monster making a bid, that will appear to be attractive to most holders, but actually steals the company for a fraction of it's future profits.
Right now...I fear a bid by Roche or similar at $1.20-$1.70 that the inexperienced retail shareholders will see as generous, given the 18months share price history, and we will lose all the upside.
Ann: SubB2M/CA15.3 Clinical Validation Data Investor Presentation, page-32
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.0¢ |
Change
-0.010(1.67%) |
Mkt cap ! $65.06M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 60.0¢ | 59.0¢ | $17.47K | 29.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 41547 | 58.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.0¢ | 13799 | 4 |
View Market Depth
| Last trade - 15.51pm 26/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |